Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 24, 2018 08:00 ET | Source: scPharmaceuticals Inc.

scPharmaceuticals Announces Appointment of Two New Directors

BURLINGTON, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
June 28, 2018 08:00 ET | Source: scPharmaceuticals Inc.

scPharmaceuticals Appoints Frederick Hudson to Board of Directors

BURLINGTON, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
June 13, 2018 08:00 ET | Source: scPharmaceuticals Inc.

scPharmaceuticals Receives Complete Response Letter from the FDA for FUROSCIX®

BURLINGTON, Mass., June 13, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
May 31, 2018 08:30 ET | Source: scPharmaceuticals Inc.

scPharmaceuticals Inc. Provides Regulatory Update on FUROSCIX®

BURLINGTON, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
May 30, 2018 08:00 ET | Source: scPharmaceuticals Inc.

scPharmaceuticals Inc. to Present at the Jefferies 2018 Global Healthcare Conference

BURLINGTON, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
May 07, 2018 16:01 ET | Source: scPharmaceuticals Inc.

scPharmaceuticals Inc. Reports First Quarter 2018 Financial Results and Provides Business Update

Company’s lead investigational product, FUROSCIX®, has a PDUFA date of June 23, 2018 Company has initiated staged commercialization activities for FUROSCIX BURLINGTON, Mass., May 07, 2018 (GLOBE...
March 20, 2018 19:22 ET | Source: scPharmaceuticals Inc.

scPharmaceuticals Inc. Reports Fourth Quarter 2017 Financial Results

Announced $147.7 Million of equity capital raising in 2017; Completed an Initial Public Offering; Advances towards FUROSCIX™ PDUFA date BURLINGTON, Mass., March 20, 2018 (GLOBE NEWSWIRE) --...
March 01, 2018 08:00 ET | Source: scPharmaceuticals Inc.

scPharmaceuticals Inc. to Present at the Cowen 38th Annual Health Care Conference

BURLINGTON, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
February 06, 2018 08:00 ET | Source: scPharmaceuticals Inc.

scPharmaceuticals Inc. to Present at the 7th Annual Leerink Partners Global Healthcare Conference

BURLINGTON, Mass., Feb. 06, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
December 12, 2017 08:00 ET | Source: scPharmaceuticals Inc.

scPharmaceuticals Inc. to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference

BURLINGTON, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...